News & Trends - MedTech & Diagnostics
Australian medtech launches first dedicated lung scanner at major congress
MedTech News: An Australian medtech company unveiled a breakthrough lung scanning device at the 2022 annual meeting of the Radiological Society of North America (RSNA) in Chicago, that integrates fluoroscopy with advanced analytics software.
4DMedical’s XV Scanner provides significant technological and competitive advantages over existing imaging modalities that will improve the quality of life for patients with respiratory issues.
It is the first dedicated lung scanner to provide non-invasive functional insights into breathing lungs, with images that provide unprecedented clinical detail and actionable information.
“In the history of scanning technology, there have been very few fundamentally new approaches introduced since the 1970s and only seven scanning modalities introduced in the past 127 years,” said Andreas Fouras, PhD, founder and CEO of 4DMedical.
“We believe the XV Scanner is the ‘Eighth Modality.’ I’m proud that it represents a meaningful breakthrough in lung scanning and disease diagnostics capability that can help patients struggling with respiratory issues. These include veterans and those suffering from long-term COVID-19. This year’s RSNA meeting is the first opportunity for radiologists and other clinicians to view the XV Scanner in person. It’s clear the $31 billion global lung imaging market is ripe for disruption, and 4DMedical will be a major player in that process.”
Current lung imaging modalities include X-ray, high-res CT, and nuclear medicine. They represent trade-offs between accuracy, sensitivity, cost, and high radiation exposure. Importantly, these modalities don’t provide combined insights into the structure and function of a patient’s lungs at the regional level.
The XV Scanner is the first dedicated lung scanner to provide clinicians with both qualitative and quantitative metrics, including regional ventilation volume, ventilation defect percentage, and ventilation heterogeneity. These metrics are produced as colour-coded images, corresponding to functionality by lung region.
Using the XV Scanner, physicians can detect areas of high and low ventilation with pinpoint accuracy—across all parts of the lung and in all phases of a single breath. The scan takes 5 seconds to perform and delivers less radiation than a typical chest X-ray.
The 4DMedical XV Scanner will now be placed at a major U.S. teaching hospital, providing unique capabilities and functional insights for lung disease research.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
APAC medtech company scores TGA approval in heart disease
MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]
MoreNews & Trends - MedTech & Diagnostics
New state-based pilot to back home-grown medtech innovation
MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]
MoreNews & Trends - Pharmaceuticals
Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis
Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]
MoreNews & Trends - Pharmaceuticals
Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives
Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]
More